Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Outcome of the 38th Annual General Meeting...more...
Outcome of the 38th Annual General Meeting of the Company.more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of AGM Notice e-Voting and Book Closure information.more...
We are submitting the Copy of the unabridged Annual Report for the financial year ended 31.03.2025.more...
Bal Pharma Ltd. on Thursday 29 May 2025 has announced Final dividend of 12 percent on Equity Share to its shareholders holding shares on the...more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...
The Board of Directors at their meeting held on 11.08.2025 has fixed 18th September 2025 as record date for the payment of dividend for the ...more...
Bal Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Sep-2025.more...
The company reported standalone net profit of Rs 0.32 crore for the quarter ended June 30 2025 as compared to Rs 1.75 crore in the same peri...more...
Bal Pharma Limited has submitted to the Exchange the financial results for the period ended Jun 30 2025.more...
Unaudited financial results ( Standalone and consolidated ) for the quarter ended 30.06.2025.more...
Board of Directors of the Company has met today and inter alia transacted the following business \r\n1. Approved the unaudited financial results ( st...more...
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider a...more...
As of June 2025 50.86% is owned by Promoters and 49.14% by Public. Among Promoters holding Indian Promoters holds 46.75% and Foreign Promote...more...
Certificate as per Regulation 3(5) and 3(6) of SEBI(PIT) Regulations 2015 for the quarter ended 30.06.2025.more...
Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 30.06.2025.more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication on notice issued for Postal Ballot.more...
Enter Stock
BOARD MEETINGS Company Name : Sacheta Metals L Date : 04-10-2025